Schedule 13G ownership disclosure
RTI Biologics, Inc.
Security class unavailable · CUSIP: 74975N105
Event date: 2019-03-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,779,387
- Percent of class
- 6.5400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-015945
- Form type
- SC 13G
- Filer
- Glen Capital Partners Focus Fund, L.P.
- CIK
- CIK 1572382
- Filed
- Mar 19, 2019
- Reporting period
- Mar 18, 2019
- Description
- Schedule 13G beneficial ownership